Insights from analysts' 12-month price targets are revealed, presenting an average target of $543.83, a high estimate of $600 ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One™ Chemistry Analyzer. Engineered to ...

Advanced technology expands the leading line of IDEXX point-of-care analyzers and combines a full chemistry panel with electrolytes and total T4 (thyroxine) into a single sample run to deliver ...

WESTBROOK, Maine, Jan.13, 2014 /PRNewswire/ --IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One' Chemistry ...